At Taylor & Francis, we are dedicated to providing quality, data-driven research to help drive successful patient outcomes, advance discovery and innovations, and support progress toward a better future.
As the largest international publisher of Substance Use journals, we are passionate about supporting progress and innovation in the prevention and treatment of addiction disorders.
Taylor & Francis’ Medicine & Health Substance Use portfolio of rigorous, evidence-based peer-reviewed research has influenced policies put forth by the Analysis & Policy Observatory (APO), World Health Organization (WHO), National Academies Press, National Institute for Health and Care Excellence, UK Government, Centers for Disease Control and Prevention (CDC), the World Bank and many more.
A sample selection of our policy articles can be found further down this page.